Answers are grounded in this paper and cite their sources.
Background: Vascularized periosteal flaps (VPFs) provide cellular and vascular support to enhance bone regeneration in complex bone defects. Despite promising biological properties, their clinical effectiveness remains incompletely defined. This systematic review and meta-analysis evaluated the efficacy of VPFs in bone defect reconstruction in animal and human studies. Methods: PubMed, Cochrane, and Embase were searched in November 2025 for controlled animal and controlled or uncontrolled human studies of VPF reconstruction. Primary outcomes were bone union, bone density, mechanical strength, histological findings, and complications. Animal risk of bias was assessed with the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) tool. Random-effects meta-analyses were performed for controlled comparisons; single-arm human studies were summarized descriptively. Results: Thirty-one studies were included: 9 controlled animal studies (234 animals) and 22 uncontrolled human studies (274 patients). In animal models, VPFs significantly improved bone union versus controls (odds ratio, 8.36; 95% confidence interval, 3.58–19.54; I 2 = 0%) and increased bone density (Hedges g = 0.96; 95% confidence interval, 0.20–1.73; I 2 = 65%). In human studies, bone union was achieved in 248 of 273 (90.8%) patients. Among long-bone defects, union reached 92.7%. Mean time to union was 15.1 weeks. Complications occurred in 16.0% of patients. Conclusions: VPFs enhanced bone regeneration in animal models and showed high union rates in human clinical studies. They represent a promising adjunct for complex bone defects, but high-quality prospective studies are needed to define their clinical role.
No takes yet. Share an insight, caveat, or question.
Eeuwen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: